NCT07378397Enrolling by invitation
OPM MEG in Pre-surgical Mapping for Patients With Epilepsy
Evaluating Novel OPM-magnetoencephalography in Pre-surgical Mapping for Patients With Epilepsy
Source: ClinicalTrials.gov · Last updated 30 Jan 2026
Brief summary (registry, in English)
Magnetoencephalography, or "MEG", is a brain-scanning method which has been available for many years. It is used in the UK and worldwide to help patients with epilepsy, who need surgery to resolve their seizures. The MEG scan can help inform the surgeon about where to operate, by mapping the abnormal brain activity caused by epilepsy. During a traditional MEG recording, patients sit very still with their head in a rigid helmet which houses many tiny sensors. This can be uncomfortable, and there are additional problems if the patient is a child, because the helmet is often too big. It is not possible to record useful data from the very youngest children with a traditional MEG scanner. But there is a new generation of MEG systems, called OPM-MEG, which employ lightweight sensors housed in a kind of hat. The hat can be appropriately sized for children, and the patient can move comfortably. The new systems are also more cost-effective to run. It is important to know whether the accepted clinical protocols for using MEG in planning epilepsy surgery can be directly transferred to OPM-MEG. It is also important to understand how the patient experience compares across systems. In this project, 20 volunteer patients will be recruited from among those children already having routine pre-surgical MEG recordings Aston University. They will be invited to participate in an OPM-MEG recording in the same facility at Aston University, so that data from the new OPM-MEG device can be compared with the data from the old MEG scanner. Data analysis pipelines will be streamlined, and the accuracy of the results compared to determine whether the improved sensor arrangement for children in the OPM-MEG system leads to better localisation of epileptiform activity.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 19 Jan 2026
- Start date
- 17 Jun 2025
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Aston University
- Diseases
- Epilepsy
- NCT number
- NCT07378397
What you commit to
- Study type: Observational
- Planned participants: 20
- From 17 Jun 2025 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients, or parent or caregiver, who do not assent or consent to participate in the research either on that day or later.
Who the study is looking for
- Patients who are capable of giving informed assent, and have a person with parental responsibility capable of giving informed consent on their behalf.
- Male or female.
- Patients between the age of 6-15 years
- Patients and caregivers with English language skills that enable informed assent/consent.
Criteria the registry did not label
- All patients referred to the Aston IHN MEG service from Birmingham Children's Hospital Children's Epilepsy Surgery Service, who are between the ages of 6 and 15, are eligible to take part in the study, until 20 patients have completed the study.
Age in the registry: 6 years to 15 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aston University Coordinator of this site? Confirm its status | Birmingham | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.